Morgan Henson

529 total citations
18 papers, 150 citations indexed

About

Morgan Henson is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Emergency Medicine. According to data from OpenAlex, Morgan Henson has authored 18 papers receiving a total of 150 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Emergency Medicine. Recurrent topics in Morgan Henson's work include Sepsis Diagnosis and Treatment (7 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers) and Poisoning and overdose treatments (2 papers). Morgan Henson is often cited by papers focused on Sepsis Diagnosis and Treatment (7 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers) and Poisoning and overdose treatments (2 papers). Morgan Henson collaborates with scholars based in United States and United Kingdom. Morgan Henson's co-authors include Antonella Borgatti, Brian D. Husbands, Claire M. Cannon, Lauren Page Black, Srinivasa T. Reddy, Faheem W. Guirgis, Lyle L. Moldawer, Christiaan Leeuwenburgh, Elizabeth DeVos and Frederick A. Moore and has published in prestigious journals such as Critical Care Medicine, Critical Care and Annals of Emergency Medicine.

In The Last Decade

Morgan Henson

18 papers receiving 148 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morgan Henson United States 8 59 56 23 23 22 18 150
Naohiko Chohnabayashi Japan 8 65 1.1× 154 2.8× 15 0.7× 49 2.1× 14 0.6× 37 282
Nahed A. Makhlouf Egypt 9 105 1.8× 27 0.5× 33 1.4× 14 0.6× 10 0.5× 51 239
Remi Beunders Netherlands 10 67 1.1× 29 0.5× 30 1.3× 7 0.3× 26 1.2× 14 245
Sarayut Supapannachart Thailand 9 83 1.4× 71 1.3× 29 1.3× 26 1.1× 23 1.0× 21 341
I. V. Mayev Russia 8 93 1.6× 51 0.9× 163 7.1× 15 0.7× 11 0.5× 16 280
Hannah Smith United States 6 32 0.5× 16 0.3× 18 0.8× 25 1.1× 38 1.7× 13 254
Friso M. de Beer Netherlands 5 115 1.9× 64 1.1× 18 0.8× 11 0.5× 19 0.9× 10 227
Rachid Attou Belgium 9 61 1.0× 30 0.5× 45 2.0× 12 0.5× 23 1.0× 31 214
Shannon Keisling United States 4 106 1.8× 70 1.3× 16 0.7× 18 0.8× 13 0.6× 6 283
Yewande Odeyemi United States 7 52 0.9× 49 0.9× 17 0.7× 10 0.4× 17 0.8× 26 231

Countries citing papers authored by Morgan Henson

Since Specialization
Citations

This map shows the geographic impact of Morgan Henson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgan Henson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgan Henson more than expected).

Fields of papers citing papers by Morgan Henson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgan Henson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgan Henson. The network helps show where Morgan Henson may publish in the future.

Co-authorship network of co-authors of Morgan Henson

This figure shows the co-authorship network connecting the top 25 collaborators of Morgan Henson. A scholar is included among the top collaborators of Morgan Henson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgan Henson. Morgan Henson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sheikh, Sophia, et al.. (2024). Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity. Drugs - Real World Outcomes. 11(3). 377–388. 1 indexed citations
2.
Guirgis, Faheem W., Lauren Page Black, Morgan Henson, et al.. (2024). The Lipid Intensive Drug Therapy for Sepsis Phase II Pilot Clinical Trial*. Critical Care Medicine. 52(8). 1183–1193. 5 indexed citations
3.
Sheikh, Sophia, Rosemarie Fernandez, Carmen Smotherman, et al.. (2023). A pilot study to identify pharmacogenomic and clinical risk factors associated with opioid related falls and adverse effects in older adults. Clinical and Translational Science. 16(11). 2331–2344. 3 indexed citations
5.
Guirgis, Faheem W., Vinitha Jacob, Morgan Henson, et al.. (2023). DHCR7 Expression Predicts Poor Outcomes and Mortality From Sepsis. Critical Care Explorations. 5(6). e0929–e0929. 7 indexed citations
6.
Driver, Brian E., et al.. (2022). Clinical predictors of endotracheal intubation in patients presenting to the emergency department with angioedema. The American Journal of Emergency Medicine. 63. 44–49. 1 indexed citations
8.
Guirgis, Faheem W., Christiaan Leeuwenburgh, Lyle L. Moldawer, et al.. (2021). Lipid and lipoprotein predictors of functional outcomes and long-term mortality after surgical sepsis. Annals of Intensive Care. 11(1). 82–82. 9 indexed citations
9.
Guirgis, Faheem W., Lauren Page Black, Morgan Henson, et al.. (2021). A hypolipoprotein sepsis phenotype indicates reduced lipoprotein antioxidant capacity, increased endothelial dysfunction and organ failure, and worse clinical outcomes. Critical Care. 25(1). 341–341. 31 indexed citations
10.
Sheikh, Sophia, Morgan Henson, Eric S. Edgerton, et al.. (2021). Opioid Overdose Risk in Patients Returning to the Emergency Department for Pain. Pain Medicine. 22(9). 2100–2105. 4 indexed citations
11.
Guirgis, Faheem W., Lauren Page Black, Elizabeth DeVos, et al.. (2020). Lipid intensive drug therapy for sepsis pilot: A Bayesian phase I clinical trial. Journal of the American College of Emergency Physicians Open. 1(6). 1332–1340. 8 indexed citations
12.
Black, Lauren Page, Michael A. Puskarich, Morgan Henson, et al.. (2020). Quantitative and Qualitative Assessments of Cholesterol Association With Bacterial Infection Type in Sepsis and Septic Shock. Journal of Intensive Care Medicine. 36(7). 808–817. 7 indexed citations
13.
Fishe, Jennifer N., et al.. (2020). Methods and implementation of a pediatric asthma pharmacogenomic study in the emergency department setting. Pharmacogenetics and Genomics. 30(9). 201–207. 3 indexed citations
14.
Sheikh, Sophia, Carmen Smotherman, Colleen Kalynych, et al.. (2020). Predicting Pain-Related 30-Day Emergency Department Return Visits in Middle-Aged and Older Adults. Pain Medicine. 21(11). 2748–2756. 5 indexed citations
15.
Guirgis, Faheem W., Lauren Page Black, Martin D. Rosenthal, et al.. (2019). LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P): Phase I/II clinical trial protocol of lipid emulsion therapy for stabilising cholesterol levels in sepsis and septic shock. BMJ Open. 9(9). e029348–e029348. 20 indexed citations
16.
Henson, Morgan, et al.. (2018). 237 Clinical Predictors for Older Adult Emergency Department Revisits for Pain. Annals of Emergency Medicine. 72(4). S94–S95. 1 indexed citations
18.
Cannon, Claire M., Antonella Borgatti, Morgan Henson, & Brian D. Husbands. (2015). Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma. Journal of Small Animal Practice. 56(7). 425–429. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026